Machine Learning Developed a Programmed Cell Death Signature for Predicting Prognosis, Ecosystem, and Drug Sensitivity in Ovarian Cancer
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Machine Learning Developed a Programmed Cell Death Signature for Predicting Prognosis, Ecosystem, and Drug Sensitivity in Ovarian Cancer
Authors
Keywords
-
Journal
Analytical Cellular Pathology
Volume 2023, Issue -, Pages 1-21
Publisher
Hindawi Limited
Online
2023-10-12
DOI
10.1155/2023/7365503
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cuproptosis Regulates Microenvironment and Affects Prognosis in Prostate Cancer
- (2023) Chao Li et al. BIOLOGICAL TRACE ELEMENT RESEARCH
- Serum Exosomes From Epithelial Ovarian Cancer Patients Contain LRP1, Which Promotes the Migration of Epithelial Ovarian Cancer Cell
- (2023) Wei Zhou et al. MOLECULAR & CELLULAR PROTEOMICS
- Ferroptosis in cancer therapy: a novel approach to reversing drug resistance
- (2022) Chen Zhang et al. Molecular Cancer
- Machine learning-based integration develops an immune-derived lncRNA signature for improving outcomes in colorectal cancer
- (2022) Zaoqu Liu et al. Nature Communications
- Programmed Cell Death Tunes Tumor Immunity
- (2022) Jing Liu et al. Frontiers in Immunology
- RB1 Is an Immune-Related Prognostic Biomarker for Ovarian Cancer
- (2022) Biao Xie et al. Frontiers in Oncology
- Transformable ECM Deprivation System Effectively Suppresses Renal Cell Carcinoma by Reversing Anoikis Resistance and Increasing Chemotherapy Sensitivity
- (2022) Lu Wang et al. ADVANCED MATERIALS
- Machine learning-based tumor-infiltrating immune cell-associated lncRNAs for predicting prognosis and immunotherapy response in patients with glioblastoma
- (2022) Hao Zhang et al. BRIEFINGS IN BIOINFORMATICS
- NCCN Guidelines® Insights: Ovarian Cancer, Version 3.2022
- (2022) Deborah K. Armstrong et al. Journal of the National Comprehensive Cancer Network
- Leveraging diverse cell-death patterns to predict the prognosis and drug sensitivity of triple-negative breast cancer patients after surgery
- (2022) Yutian Zou et al. International Journal of Surgery
- Identification of bromodomain-containing proteins prognostic value and expression significance based on a genomic landscape analysis of ovarian serous cystadenocarcinoma
- (2022) Juan Zhang et al. Frontiers in Oncology
- Autophagy in major human diseases
- (2021) Daniel J Klionsky et al. EMBO JOURNAL
- Integration of scRNA-Seq and Bulk RNA-Seq to Analyse the Heterogeneity of Ovarian Cancer Immune Cells and Establish a Molecular Risk Model
- (2021) Leilei Liang et al. Frontiers in Oncology
- Identification of the pyroptosis‑related prognostic gene signature and the associated regulation axis in lung adenocarcinoma
- (2021) Wanli Lin et al. Cell Death Discovery
- Integrative analysis from multi-center studies identities a consensus machine learning-derived lncRNA signature for stage II/III colorectal cancer
- (2021) Zaoqu Liu et al. EBioMedicine
- Large-scale public data reuse to model immunotherapy response and resistance
- (2020) Jingxin Fu et al. Genome Medicine
- Targeting tumor microenvironment in ovarian cancer: Premise and promise
- (2020) Yuting Jiang et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- TIMER2.0 for analysis of tumor-infiltrating immune cells
- (2020) Taiwen Li et al. NUCLEIC ACIDS RESEARCH
- The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications
- (2020) Yuanyuan Zhang et al. Cellular & Molecular Immunology
- An immune-related gene signature for predicting survival and immunotherapy efficacy in hepatocellular carcinoma
- (2020) Yifei Dai et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Single-cell landscape of the ecosystem in early-relapse hepatocellular carcinoma
- (2020) Yunfan Sun et al. CELL
- Hypoxia-Mediated Decrease of Ovarian Cancer Cells Reaction to Treatment: Significance for Chemo- and Immunotherapies
- (2020) Aleksandra Klemba et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Delivery technologies for cancer immunotherapy
- (2019) Rachel S. Riley et al. NATURE REVIEWS DRUG DISCOVERY
- The molecular machinery of regulated cell death
- (2019) Daolin Tang et al. CELL RESEARCH
- Combination of TMB and CNA stratifies prognostic and predictive responses to immunotherapy across metastatic cancer
- (2019) Li Liu et al. CLINICAL CANCER RESEARCH
- Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018
- (2018) Lorenzo Galluzzi et al. CELL DEATH AND DIFFERENTIATION
- How the Warburg effect supports aggressiveness and drug resistance of cancer cells?
- (2018) Philippe Icard et al. DRUG RESISTANCE UPDATES
- BRD4 amplification facilitates an oncogenic gene expression program in high-grade serous ovarian cancer and confers sensitivity to BET inhibitors
- (2018) Garrett W. Rhyasen et al. PLoS One
- Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade
- (2017) Pornpimol Charoentong et al. Cell Reports
- Cancer mediates effector T cell dysfunction by targeting microRNAs and EZH2 via glycolysis restriction
- (2015) Ende Zhao et al. NATURE IMMUNOLOGY
- Dexamethasone enhances necrosis-like neuronal death in ischemic rat hippocampus involving μ-calpain activation
- (2014) Georg Johannes Müller et al. EXPERIMENTAL NEUROLOGY
- Fatty acid synthase inhibition engages a novel caspase-2 regulatory mechanism to induce ovarian cancer cell death
- (2014) C-S Yang et al. ONCOGENE
- Inferring tumour purity and stromal and immune cell admixture from expression data
- (2013) Kosuke Yoshihara et al. Nature Communications
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now